We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Punctured devolution

7 November 2003 By Robert Cyran

After two decades, the German conglomerate has realised that separating chemicals and pharma is a sure recipe for value creation. Bayer could still bungle the reorganisation, but there s little question that separation will benefit the company.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)